Nanomedicine as a putative approach for active targeting of hepatocellular carcinoma

MLA

Muhammed H. Elnaggar, et al. “Nanomedicine as a Putative Approach for Active Targeting of Hepatocellular Carcinoma.” Seminars in Cancer Biology, vol. 69, Feb. 2021, pp. 91–99. EBSCOhost, https://doi.org/10.1016/j.semcancer.2019.08.016.

APA

Muhammed H. Elnaggar, Shurouk A. Moatamed, Dina Johar, Somia Attia, Aya Samir, Hadeer M. Lamloum, Amira Yasmine Benmelouka, Abdelrahman Ibrahim Abushouk, Hossam Abd-Elmegeed, Samy Zaky, Ahmed H.E. Hassan, & Nouran Amr. (2021). Nanomedicine as a putative approach for active targeting of hepatocellular carcinoma. Seminars in Cancer Biology, 69, 91–99. https://doi.org/10.1016/j.semcancer.2019.08.016

Chicago

Muhammed H. Elnaggar, Shurouk A. Moatamed, Dina Johar, Somia Attia, Aya Samir, Hadeer M. Lamloum, Amira Yasmine Benmelouka, et al. 2021. “Nanomedicine as a Putative Approach for Active Targeting of Hepatocellular Carcinoma.” Seminars in Cancer Biology 69 (February): 91–99. doi:10.1016/j.semcancer.2019.08.016.